Find your path to Giles
1,057 people in our graph share verified history with Giles — schools, employers, funds. One of them is your warm intro.
René KuijtenunlockedGiles: together at Utrecht University (1984–1989)
×2Giles: together at University of Illinois Chicago
×7Giles: together at MIT/Whitehead Center for Genome Research
Giles: together at Pfizer
About
Giles Day is Co-Founder, CEO, and President of Reverb Therapeutics, a company focused on drug discovery and development. His work centers on pharmaceutical research and development aimed at personalized patient care across therapeutic areas.
Co-founder at Ability
Intro paths
→
In turn, Giles can intro founders to Ability's investors below.
Ability's investors · 3
Experience
- Reverb TherapeuticsCo-Founder, CEO & Presidentcurrent2022 — presentVancouver, British Columbia, Canada
- NewCoCo-founder and Board Chaircurrent2024 — present
- Ability BiologicsChairpersoncurrent2022 — presentMontreal, QC
- Inkling LLCManaging Partnercurrent2018 — presentNewton, Massachusetts, United States
- Abcuro, IncStrategic Advisor2022 — 2023Newton, Massachusetts, United States
- Abcuro, IncPresident & CEO2020 — 2022Newton, Massachusetts, United States
- Comet Therapeutics (exited, VectivBio)CEO and President2018 — 2020Cambridge, MA
- Partners HealthCare InnovationEntrepreneur in Residence2018Greater Boston Area
- Syntimmune (exited, Alexion, $1.2B)CEO2016 — 2018Waltham, MA
- MIT Center for Cancer Systems BiologyScientific Advisory Board Member2011 — 2018Cambridge, MA
- Apple Tree PartnersVenture Partner2015 — 2016Cambridge, MA
- Flagship VentureLabsEntrepreneur in Residence2015Cambridge, MA
- Selventa (exited, Alexion)Executive Chairman2015Cambridge, MA
- Go TherapeuticsAdvisory Board Member2014 — 2015Cambridge
- SelventaCEO and President2010 — 2015Cambridge, MA
- SelventaChief Scientific Officer2010Cambridge, MA
- Boehringer IngelheimVP Biotherapeutics and Integrative Biology2008 — 2010
- PfizerDirector, Head of Systems biology2005 — 2008
- AstraZenecaAssociate director Computational Biology2000 — 2005
- MIT/Whitehead Center for Genome ResearchHead Target Validation1997 — 2000
Skills & more
Systems Biology99Life Sciences99Biopharmaceuticals81Molecular Biology44Pharmaceuticals4Biotechnology99Drug Discovery99R&D39Genomics51Computational Biology99Genetics10Research4
+11 more
OncologyClinical ResearchBioinformaticsImmunologyTranslational ResearchLifesciencesPharmaceutical IndustrySciencePurificationTeam LeadershipStrategyLanguages Dutch · English · French · German · Hebrew
From Giles's professional profile.
Frequently asked questions
- Who is Giles Day?
- Giles Day is Co-Founder, CEO, and President of Reverb Therapeutics, a company focused on drug discovery and development. His work centers on pharmaceutical research and development aimed at personalized patient care across therapeutic areas.
- Where does Giles Day work?
- Giles Day is Co-founder of Ability.
- What companies did Giles Day found?
- Giles Day founded Ability.
- Where did Giles Day go to school?
- Giles Day studied at Utrecht University (MSc, Evolutionary Genetics); Weizmann Institute of Science (Postdoctoral, Genomics); University of Illinois Chicago (PhD, Mammalian Genetics).
Founder mafias
University of Illinois Chicago mafia47
Also came through, then founded or led a company.
Chris LiMaster's degreeFounded Oak +1Mohamed GeneadMedical Retina Fellowship | Ophthalmologist | Retina SpecialistFounded Aviceda Therapeutics +1Ben AlbertMBAFounded Upfront Healthcare +1Adam KhanBSFounded Diamondquanta +1Sam BlackmanPhDFounded Day One BiopharmaceuticalsAnshul SadanaMSFounded Nexthop
+ 40 more
Utrecht University mafia36
Also came through, then founded or led a company.
Lukas DerksenCertificateFounded Sidlee +3Vanessa LiuInternational LawFounded Sugarwork +1Joris StraatmanBAFounded Juli +1Maarten EngelenArtificial IntelligenceFounded HiberMartin WilleminkDoctor of Philosophy (PhD)Founded SegmedGiulio CantoroSummer SchoolFounded Blink Last Mile
+ 29 more
Weizmann Institute of Science mafia23
Also came through, then founded or led a company.
Douglas J. JollyPost-DocFounded Abintus Bio +1Valerian NakaarM.Sc.Founded Carogen Corporaton +1Yaron DanielyPost-DocFounded YissumPete FlintInternational Summer Science SchoolFounded Signal NFXMaya Ben DrorMinerva School on AlternativeFounded ComplexChaosTal ShapiraM.ScFounded Triple W
.jpg)
+ 16 more
Same school
Also attended Utrecht University159
René KuijtenInvestor at LSP (Life Sciences Partners)Alina GouninaInvestor at Moonfire VenturesAlex PortoInvestor at Riverwood CapitalBas JongtienLegal Counsel at DOB EquityMatthijs BlokhuisDirecteur at NoaberRoel DekkersInvestment manager at Noaber
+ 153 more
Also attended Weizmann Institute of Science37
Yaron DanielyGeneral Partner & Head of aMoon Alpha at aMoonReut ShemaPartner at aMoonHagai Marmor-KolletAssociate at aMoonItzik ParnafesVenture Partner at Key1 CapitalPete FlintInvestor at NFXShiran Tehila MashiahPrincipal at Peregrine Ventures
+ 31 more
Also attended University of Illinois Chicago89
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Kate WilschutzChief Financial Officer, Revolution Funds at RevolutionSteve ShafferOperating Partner at Volition CapitalAnshul SadanaCEO, Nexthop AI at EMERGENT VENTURESStefano GaliassoVice President at Energy Capital VenturesBoris GyllhamnInvestment Manager at Almi Invest GreenTech
+ 83 more
Shared employers
Also worked at Ability Biologics3
Also worked at Abcuro, Inc1
Also worked at Apple Tree Partners9
Victor RusuPrincipal at MPM BioImpactJernej GodecPrincipal at Atlas VentureSamuel HallManaging Partner at Scion Life SciencesAaron KantoffManaging Partner at Scion Life SciencesAndreas LoewPartner at Scion Life SciencesHuw NashVenture Partner at Scion Life Sciences
+ 3 more
